Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$155M |
| 2 |
Amazon
AMZN
|
+$112M |
| 3 |
Illumina
ILMN
|
+$97.7M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$69.6M |
| 5 |
Advanced Micro Devices
AMD
|
+$60.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$419M |
| 2 |
Palantir
PLTR
|
+$188M |
| 3 |
Robinhood
HOOD
|
+$164M |
| 4 |
XYZ
Block Inc
XYZ
|
+$139M |
| 5 |
Unity
U
|
+$123M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.6% |
| 2 | Healthcare | 21.37% |
| 3 | Communication Services | 18.23% |
| 4 | Consumer Discretionary | 15.37% |
| 5 | Financials | 11.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.43T
| $1.33B | 11.06% |
3,287,352
-1,301,429
| -28% | -$419M |
|
2
Roku
ROKU
$23.4B
| $793M | 6.61% |
10,671,956
-550,091
| -5% | -$41.7M |
|
3
Coinbase
COIN
$49.2B
| $754M | 6.28% |
3,034,645
-206,553
| -6% | -$52.4M |
|
|
4
Palantir
PLTR
$432B
| $589M | 4.91% |
7,793,443
-3,224,331
| -29% | -$188M |
|
5
Roblox
RBLX
$27.4B
| $587M | 4.89% |
10,142,551
-1,698,859
| -14% | -$85.5M |
|
|
6
Robinhood
HOOD
$97.2B
| $481M | 4.01% |
12,907,172
-5,067,173
| -28% | -$164M |
|
7
Shopify
SHOP
$192B
| $479M | 3.99% |
4,505,024
-165,880
| -4% | -$16.1M |
|
|
XYZ
8
Block Inc
XYZ
$49.4B
| $419M | 3.49% |
4,927,919
-1,697,551
| -26% | -$139M |
|
|
9
CRISPR Therapeutics
CRSP
$5.75B
| $353M | 2.94% |
8,973,064
+1,474,439
| +20% | +$69.6M |
|
10
Archer Aviation
ACHR
$4.85B
| $292M | 2.43% |
29,912,089
+6,371,647
| +27% | +$35.4M |
|
11
ARK 21Shares Bitcoin ETF
ARKB
$2.94B
| $289M | 2.41% |
9,300,696
-128,694
| -1% | -$3.56M |
|
12
Meta Platforms (Facebook)
META
$1.4T
| $272M | 2.26% |
464,394
+66,473
| +17% | +$39M |
|
13
Twist Bioscience
TWST
$9.13B
| $260M | 2.17% |
5,595,865
+237,772
| +4% | +$10.7M |
|
14
UiPath
PATH
$8.49B
| $249M | 2.07% |
19,602,729
-1,347,073
| -6% | -$17.8M |
|
15
Teradyne
TER
$58.7B
| $242M | 2.02% |
1,923,010
+390,397
| +25% | +$46.2M |
|
16
Recursion Pharmaceuticals
RXRX
$1.88B
| $219M | 1.82% |
32,346,398
-422,788
| -1% | -$2.84M |
|
17
DraftKings
DKNG
$13B
| $206M | 1.71% |
5,534,168
-490,565
| -8% | -$19.5M |
|
|
18
Amazon
AMZN
$2.79T
| $196M | 1.64% |
895,085
+546,252
| +157% | +$112M |
|
|
TEM
19
Tempus AI
TEM
$13.1B
| $186M | 1.55% |
5,519,644
+3,141,487
| +132% | +$155M |
|
20
Beam Therapeutics
BEAM
$3.07B
| $175M | 1.46% |
7,068,029
+536,930
| +8% | +$13.7M |
|
21
10x Genomics
TXG
$8.48B
| $172M | 1.43% |
11,944,057
+1,193,712
| +11% | +$18.8M |
|
22
Veracyte
VCYT
$3.4B
| $166M | 1.39% |
4,203,951
-716,794
| -15% | -$27.1M |
|
23
PagerDuty
PD
$950M
| $164M | 1.37% |
8,996,347
-754,877
| -8% | -$14.5M |
|
24
Trade Desk
TTD
$6.19B
| $149M | 1.24% |
1,271,113
+5,548
| +0.4% | +$686K |
|
25
Intellia Therapeutics
NTLA
$1.8B
| $146M | 1.22% |
12,536,386
+280,946
| +2% | +$4.38M |
|
Similar funds
Cathie Wood's Q4 2024 Portfolio in Review
As of Q4 2024, Cathie Wood held 194 positions worth $12B, up 9.8% from $10.9B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Cathie Wood withdrew a net $862M in Q4 2024, closing 11 positions and reducing 123 holdings. Its most notable exit was Moderna, an estimated $77.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Cathie Wood opened a new position in Illumina worth $91.7M.
- Cathie Wood's largest Q4 2024 buy was Illumina: 686,330 shares worth $91.7M.
- Cathie Wood added most to Tempus AI in Q4 2024, an estimated $155M increase.
- Cathie Wood's biggest Q4 2024 reduction was Tesla, cutting an estimated $419M.
- Cathie Wood fully exited Moderna in Q4 2024, selling an estimated $77.8M.
- Cathie Wood's ten largest holdings make up 51% of its $12B portfolio in Q4 2024.
- Cathie Wood opened 7 new positions and closed 11 in Q4 2024.
- Cathie Wood's portfolio value rose 9.8% quarter-over-quarter to $12B.
Based on ARK Investment Management's 13F filing for Q4 2024, filed 4 Feb 2025.